Comparative Pharmacology
Head-to-head clinical analysis: METHYLENE BLUE versus VORAXAZE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: METHYLENE BLUE versus VORAXAZE.
METHYLENE BLUE vs VORAXAZE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Methylene blue is a dye that acts as a redox agent, reducing methemoglobin to hemoglobin by activating the enzyme methemoglobin reductase. It also inhibits nitric oxide synthase and guanylate cyclase, causing vasoconstriction in septic shock.
Glucarpidase is a recombinant bacterial enzyme that hydrolyzes the glutamate residue from methotrexate and its metabolites, converting them to nontoxic metabolites.
1-2 mg/kg IV over 5-30 minutes for methemoglobinemia; repeat after 1 hour if needed. Maximum dose: 7 mg/kg.
2000 units intravenously over 5 minutes as a single dose.
None Documented
None Documented
Terminal elimination half-life approximately 12–24 hours; clinically, levels may persist for 2–3 days due to enterohepatic recycling
Clinical Note
moderateMethylene blue + Torasemide
"Methylene blue may increase the hypotensive activities of Torasemide."
Clinical Note
moderateMethylene blue + Travoprost
"Methylene blue may increase the hypotensive activities of Travoprost."
Clinical Note
moderateMethylene blue + Unoprostone
"Methylene blue may increase the hypotensive activities of Unoprostone."
Clinical Note
moderateMethylene blue + Hydrochlorothiazide
Terminal elimination half-life is approximately 10 hours (range 6-16 hours) in patients with normal renal function. In patients with methotrexate-induced renal impairment, half-life may be prolonged up to 20-30 hours. Clinical context: the half-life determines the timing of repeat dosing or monitoring; a single dose typically reduces methotrexate levels by >97% within 15 minutes.
Renal (80% as leukomethylene blue and unchanged drug); biliary/fecal minor
Voraxaze (glucarpidase) is a recombinant enzyme that rapidly cleaves circulating methotrexate into inactive metabolites (DAMPA and glutamate). It is not significantly renally or hepatically excreted; rather, it is a high-molecular-weight protein that is catabolized via proteolysis. The majority of the administered dose is metabolized and eliminated as smaller peptides and amino acids. Less than 1% is excreted unchanged in urine.
Category C
Category C
Antidote
Antidote
"Methylene blue may increase the hypotensive activities of Hydrochlorothiazide."